Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Uk.ResellerClub Launches New Promotion Offering Free .CO.UK Domains With Hosting Packages

LONDON, May 10, 2013 /PRNewswire/ --  Web Presence products provider Uk.ResellerClub have...

Wirecard Gains SriLankan Airlines As A New Customer In Asia

MUNICH, Germany, April 30, 2013 /PRNewswire/ -- Wirecard AG, provider of a globally accepted payment...

Global Payments Continues Focus On Mobile Payments In The UK

LONDON, March 28, 2013 /PRNewswire/ -- Global Payments is further strengthening its mobile payment...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »


Stem cell research and experimentation has been in process for well over five decades and they have been a huge medical success story because stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being unspecialized with the ability to differentiate into specialized cell types.

The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain at the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community. 

BRUSSELS, March 19, 2013 /PRNewswire/ --

- Be2bill is the first French acquiring institution to become a VISA-certified "Merchant Agent"

- PCI DSS certification has been extended to Level 1 Service Provider

- Rentabiliweb now protects clients against all payment card processing liability and guarantees them a reduction in fraud and financial incident risk

 Be2bill, the specialized online payment solution provided by Rentabiliweb Europe, is the first acquiring institution in France to obtain "Merchant Agent" certification and the third French company to have obtained this trusted third party certification from the leading international network in the world, VISA. 

LONDON, March 18, 2013 /PRNewswire/ --

 Cantor Gaming&Wagering Ltd (UK), the Financial Fixed Odds betting service provider, today announced it has launched a collaboration with 188BET. 188BET customers can now enjoy Financial Fixed Odds betting via an integrated platform provided by Cantor Gaming & Wagering Ltd (UK). The service is available on the 188BET website. 

Cantor Gaming's innovative FFO betting service, which uses advanced Abode(TM) Flex(TM) software, integrates seamlessly into an operator's product range enabling an FFO provider's clients to bet immediately on the world's most popular financial markets.

Viropro, Inc. and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement where Viropro will have the rights to manufacture six monoclonal antibody products being developed by Oncobiologics for commercialization in more than 70 emerging market countries, excluding China.

Viropro will have exclusive commercialization rights to the six biosimilars for Malaysia. In addition, the companies will co-manage Viropro's Penang, Malaysia Alpha Biologics biomanufacturing subsidiary. The alliance will seek regional partners to drive commercialization.

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for its treatment and prevention of bacterial vaginosis (BV) with a proven cure rate of 80 percent already after one vaginal tablet.  Addressing the unmet needs of up to 300 million women suffering from BV infection, the new treatment represents a considerable commercial potential in the OTC market. 

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the culture of Personal Injury (PI) claims in the UK and reduce the payouts that have led to substantial rises in car insurance premiums. 

 The surveys say that doctors were under pressure to be part of the GBP 2 billion PI payout, not just through increasing numbers of whiplash patients taking up surgery time but with 7% actually being offered money to refer patients with whiplash injuries. 

 Over the last month, AXA polled doctors across the UK and an overwhelming 88% of those surveyed said they felt the government should introduce new measures to control whiplash claims for motorists.